Fifth Third Bancorp Has $9.93 Million Stock Holdings in SPDR S&P Biotech ETF $XBI

Fifth Third Bancorp grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 18.5% in the 1st quarter, HoldingsChannel.com reports. The fund owned 77,761 shares of the exchange traded fund’s stock after purchasing an additional 12,160 shares during the quarter. Fifth Third Bancorp’s holdings in SPDR S&P Biotech ETF were worth $9,932,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Sonata Capital Group Inc. bought a new stake in SPDR S&P Biotech ETF in the first quarter worth $204,000. Main Street Research LLC raised its holdings in SPDR S&P Biotech ETF by 57.4% during the first quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock valued at $72,484,000 after buying an additional 206,953 shares in the last quarter. Ibex Wealth Advisors bought a new position in SPDR S&P Biotech ETF during the first quarter valued at about $884,000. Kestra Advisory Services LLC lifted its position in shares of SPDR S&P Biotech ETF by 30.4% in the first quarter. Kestra Advisory Services LLC now owns 26,063 shares of the exchange traded fund’s stock worth $3,329,000 after buying an additional 6,073 shares during the last quarter. Finally, Money Concepts Capital Corp lifted its position in shares of SPDR S&P Biotech ETF by 12.4% in the first quarter. Money Concepts Capital Corp now owns 3,322 shares of the exchange traded fund’s stock worth $424,000 after buying an additional 366 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $156.22 on Thursday. The company has a market cap of $10.63 billion, a PE ratio of 11.47 and a beta of 0.82. The stock has a 50-day moving average of $141.70 and a 200-day moving average of $132.04. SPDR S&P Biotech ETF has a 52-week low of $84.39 and a 52-week high of $165.71.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.